lung disease

The company said that 20 medical centers in the US are now offering the Envisia Genomic Classifier through an early-access program begun in May.

Prospective research suggests DNA and RNA sequencing can reveal pathogen, microbiome, and host expression features to detect lower respiratory tract infections.

Single-cell RNA sequencing from mouse trachea and human bronchial epithelial cells unearthed new cell types, including ionocytes enriched for CFTR expression.

NuMedii will use its AI technology in combination with single-cell data to identify biomarkers and therapeutics for idiopathic pulmonary fibrosis.

This Week in PNAS

In PNAS this week: AKT1 mutations in pulmonary sclerosing hemangioma, genomic study of hyper-virulence in Campylobacter jejuni, and more.

Found the Talent

This year's winners of the Intel Talent Search developed software to help in drug development, a smartphone-based tool to detect lung disease, and more.

The center has already sequenced and analyzed 1,500 human genomes for the TOPMed program and will expand this effort with the new funding.

This Week in Nature

In Nature this week: genomic analysis of 200 bird species, and more.

The group hopes to find biomarkers as a first step toward identifying or developing targeted therapeutics to avoid serious and life threatening outcomes of early lung disease in these newborns.

Data for tens of thousands of UK Biobank participants revealed an overlapping set of variants involved in airflow obstruction in heavy and never smokers. 

Pages

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.